Innotesto

Innotesto is a French biotechnology company specializing in the assessment of chemical and drug effects on male reproductive health. Based in Marseille, the company utilizes proprietary ex vivo organotypic culture models of human and rodent testes to evaluate reproductive toxicity and the impact of endocrine disruptors. Their services support pharmaceutical and cosmetic companies in de-risking drug candidates and ensuring product safety regarding male fertility. By providing physiologically relevant models, Innotesto aims to bridge the gap between conventional in vitro assays and animal testing. The company's core technology allows for the maintenance of the complex architecture of the testis and the blood-testis barrier in a laboratory setting, providing high-resolution data on spermatogenesis and steroidogenesis.